Folcepri

Etarfolatide · Endocyte Europe, B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Folcepri, covering 2014-08-14 to 2014-08-14. Get the full timeline:

Most recent: EMA Application withdrawn: Folcepri (Etarfolatide) — Endocyte Europe, B.V.